All Stories

  1. Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma

    Article • OncoTargets and Therapy, October 2018, Dove Medical Press

    Dr MADAPPA N KUNDRANDA, Sunilkumar Kakadia